Cetraxal Plus is a solution for administration into the ear. It contains:
Cetraxal Plus is an ear drop solution. It is used in adults and children from 6 months of age for the treatment of acute otitis externa (inflammation of the outer ear) and otitis media (inflammation of the middle ear) with ventilation tube drainage, of bacterial origin.
Severe allergic reactions may require immediate emergency treatment.
Due to the lack of sufficient clinical data on the use of Cetraxal Plus in children under 6 months, before administering this medicine to a child of this age, you should consult a doctor.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. This also applies to medicines available without a prescription.
There have been no adequate and well-controlled studies with Cetraxal Plus in pregnant women.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, you should consult your doctor or pharmacist before using this medicine.
Given the form and route of administration, Cetraxal Plus does not affect the ability to drive or operate hazardous machinery.
Cetraxal Plus contains methyl parahydroxybenzoate (E 218) and propyl parahydroxybenzoate (E 216), which may cause allergic reactions (delayed reactions are possible).
Cetraxal Plus is intended for administration into the ear only.
Cetraxal Plus should always be used in accordance with the recommendations of your doctor or pharmacist. If you have any doubts, you should consult your doctor or pharmacist.
The recommended dose for adults and children is 6 to 8 drops into the affected ear, twice a day, for 7 days.
Cetraxal Plus can be used in both ears only if recommended by your doctor.
Your doctor will determine how long you should take Cetraxal Plus. To avoid a recurrence of the infection, do not stop treatment too early, even if the condition of the ear has improved.
The person administering Cetraxal Plus should wash their hands.
To ensure the effectiveness of the medicine in the ear, follow the administration instructions. During administration, it is not recommended to keep your head in an upright position or move it too vigorously, as this may cause the medicine to be lost, as the drops will flow down your face rather than penetrating the ear canal.
Store the bottle until the end of treatment. Do not store the medicine for later use.
There are no known symptoms of overdose. In case of overdose or accidental ingestion, you should contact your doctor or pharmacist immediately or call the poison control center, providing the name of the medicine and the amount taken, or go to the nearest medical center.
Do not take a double dose to make up for a missed dose. Take the next dose according to the schedule.
Do not stop using Cetraxal Plus without consulting your doctor or pharmacist.
It is very important to use these ear drops for the period indicated by your doctor, even if the symptoms disappear earlier. If you stop using the medicine too early, the infection may recur, and the symptoms may reappear or even worsen. Resistance to the antibiotic may also develop.
Like all medicines, Cetraxal Plus can cause side effects, although not everybody gets them.
If you experience severe allergic reactions or any of the following side effects, you should stop using the medicine immediately and inform your doctor:
swelling of the hands, feet, ankles, face, lips, mouth, or throat, difficulty swallowing or breathing, rash or hives, wounds, ulcers.
Common: may affect up to 1 in 10 people
local side effects in the ear:discomfort, pain, itching.
general side effects:taste disturbances.
Uncommon: may affect up to 1 in 100 people
local side effects in the ear:ringing, presence of residual medicine, blockage of the drain, tingling, redness, hearing impairment, rash, inflammation, fungal infection of the outer ear, ear discharge, swelling, eardrum disturbances, granuloma, middle ear infection of the other ear.
general side effects:fungal infection with Candida, irritability, excessive tear production, dizziness, skin redness, headache, vomiting, fatigue.
vision disturbances: blurred vision.
If you experience any side effects, including any not listed in the leaflet, you should inform your doctor, pharmacist, or nurse. You can also report side effects directly to the Department of Monitoring of Adverse Reactions to Medicinal Products, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181 C; 02-222 Warsaw, tel: (+48) 22 49 21 301, fax: (+48) 22 49 21 309, website: http://smz.ezdrowie.gov.pl
You can also report side effects to the marketing authorization holder or parallel importer.
Reporting side effects will help to gather more information on the safety of this medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 30°C.
Do not use Cetraxal Plus after the expiry date stated on the packaging. The expiry date refers to the last day of the given month.
After opening the bottle, do not use the medicine for more than 1 month. After opening, store in a temperature below 25°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
Cetraxal Plus is a clear, colorless or yellowish ear drop solution. The packaging is a white, opaque plastic bottle with a dropper.
Each bottle contains 10 ml of solution.
Antibiotics are used to treat bacterial infections. They are not effective against viral infections.
If your doctor has prescribed antibiotics, their use is necessary for the specific disease you are currently suffering from.
Despite the use of antibiotics, some bacteria may survive or multiply. This phenomenon is called resistance: some antibiotic therapies become ineffective.
The overuse of antibiotics leads to increased resistance. You may even contribute to the development of bacterial resistance and thus delay recovery or reduce the effectiveness of the antibiotic if you do not follow the:
Laboratorios Salvat, S.A.
C/ Gall, 30-36
08950 Esplugues de Llobregat (Barcelona)
Spain
Laboratorios Salvat, S.A.
C/ Gall, 30-36
08950 Esplugues de Llobregat (Barcelona)
Spain
Pharmaloop S.L.
C/Bolivia, 15 - Polig. Industrial Azque
28806 Alcala de Henares (Madrid)
Spain
InfectoPharm GmbH
Von-Humboldt-Str. 1
64646 Heppenheim
Germany
Polypharm S.A.
ul. Barska 33
02-315 Warsaw
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Marketing authorization number in Spain, the country of export: 866103.9
Spain
Cetraxal Plus 3 mg/ml + 0,25 mg/ml gotas óticas en solución
France
CETRAXAL 3mg / 0,25mg par ml, solution pour instillation auriculaire
Poland
Cetraxal Plus
Czech Republic
Infalin duo 3 mg/ml + 0,25 mg/ml ušní kapky, roztok
Denmark
Cetraxal Comp 3 mg/ml + 0,25 mg/ml Øredråber, opløsning
Finland
Cetraxal Comp 3 mg/ml + 0,25 mg/ml Korvatipat, liuos
Romania
Cexidal 3 mg/ml + 0,25 mg/ml Picături auriculare, soluţie
Slovakia
Infalin duo 3 mg/ml + 0,25 mg/ml Ušná roztoková instilácia
Sweden
Cetraxal Comp 3 mg/ml + 0,25 mg/ml Örondroppar, lösning
Norway
Cetraxal Comp
Iceland
Cetraxal Comp 3 mg/ml + 0,25 mg/ml Eyrnadropar, lausn
Germany
InfectoCiproCort 3 mg/ml + 0,25 mg/ml Ohrentropfen, Lösung
Date of leaflet approval: 19.05.2023
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.